RESUMO
409 cases of superficial bladder carcinoma (pTa, pTi, Tis) are reported. They are divided into three groups: 171 patients treated by TUR alone, 124 treated by TUR and local thio-TEPA, and 114 patients treated by TUR and BCG vaccine locally. It was found that the frequency of recurrence fell by 56.7, 41.9 and 26.3%, while the progression of the illness declined correspondingly by 19.8, 16.9 and 11.4%. In other words, in terms of recurrence and progression, the poorest results were found for the group treated by TUR only, and the best results were found with the TUR and BCG group.
Assuntos
Vacina BCG/uso terapêutico , Carcinoma de Células de Transição/terapia , Recidiva Local de Neoplasia/prevenção & controle , Tiotepa/uso terapêutico , Neoplasias da Bexiga Urinária/terapia , Administração Intravesical , Terapia Combinada , Humanos , Cuidados Pós-OperatóriosRESUMO
The first documented case of primary malignant giant cell tumor of the jawbones is reported. The neoplasm presented as a lytic lesion of the mandible which recurred following surgery and metastasized to the lungs and one lymph node. Diagnostic criteria are discussed, and the literature concerning malignant giant cell tumors of the jawbones is reviewed.
